Lucknow: Antibody-drug conjugate (ADC) therapy is emerging as an effective targeted treatment for cancers affecting multiple organs, doctors at King George's Medical University (KGMU) said during a workshop organized by the Georgian Alumni Association on Saturday.
What is ADC Therapy?
Prof Sudhir Singh, organizing secretary and faculty member of the radiotherapy department, explained that ADC therapy combines a cancer-targeting antibody with an anti-cancer drug. This combination delivers medication directly to cancer cells, improving precision and reducing damage to healthy cells. He noted that the therapy is showing promising results in breast, lung, and lymphoma cancers.
Role of Biomarkers in Cancer Detection
Gynaecologic oncologist Dr Zoya Siddiqui highlighted that biomarkers—biological indicators in the blood—can help detect lung cancer, identify its type, and guide treatment decisions. This approach enables personalized therapy for patients.
Importance of Immunity in Cancer Care
Prof Naseem Akhtar, faculty member of the surgical oncology department, emphasized that improving immunity through treatment and nutrition plays a crucial role in cancer care. A strong immune system can enhance the effectiveness of therapies and improve patient outcomes.
The workshop underscored the advancements in cancer treatment and the importance of multidisciplinary approaches in managing the disease.
